CellVoyant
PrivateLast Round
Seed
Jan 15, 2024
Total Funding Raised
$12.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CellVoyant operates in Healthcare & Life Sciences and is based in Bristol. Its latest recorded funding round was a Seed round in January 2024.
CellVoyant is a biotechnology company that utilizes AI-first live-cell imaging to predict and optimize stem cell differentiation for the development of novel cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellVoyant Comparables
Compare CellVoyant with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autolomous | 66% | |
| Sartorius Aktiengesellschaft | 64% | |
| Danaher | 60% |
For institutional investors. Book with your work email.
CellVoyant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 15, 2024 | ||||
| Pre Seed | Dec 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CellVoyant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Seed |
| Verve Ventures | Seed |
| Air Street Capital | Seed |
| Octopus Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 19, 106% of headcount.
- Jan 13, 2026
Integrated AI foundation models with Automata's LINQ platform for adaptive cell culture.
For institutional investors. Book with your work email.
CellVoyant Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CellVoyant's valuation, stock price, and market status.
Is CellVoyant a public or private company?
CellVoyant is a private company.
What is the current stock price of CellVoyant?
CellVoyant is a private company, so its shares have no public market price. Caplight tracks CellVoyant's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CellVoyant worth (valuation)?
Valuation information for CellVoyant is not publicly available.
Can I buy CellVoyant stock?
CellVoyant shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CellVoyant's last funding round?
CellVoyant's most recent funding round was Seed on January 15, 2024.
Who are the main investors in CellVoyant?
Key investors in CellVoyant include Octopus Ventures.
Will CellVoyant IPO soon?
No public IPO plans have been announced for CellVoyant.
How can I track CellVoyant secondary market activity?
Caplight tracks bids, offers, and trades in CellVoyant's shares on secondary markets.